145 related articles for article (PubMed ID: 27723093)
21. NADPH Oxidase Deficiency: A Multisystem Approach.
Giardino G; Cicalese MP; Delmonte O; Migliavacca M; Palterer B; Loffredo L; Cirillo E; Gallo V; Violi F; Pignata C
Oxid Med Cell Longev; 2017; 2017():4590127. PubMed ID: 29430280
[TBL] [Abstract][Full Text] [Related]
22. Chronic Granulomatous Disease in children: a single center experience.
Beghin A; Comini M; Soresina A; Imberti L; Zucchi M; Plebani A; Montanelli A; Porta F; Lanfranchi A
Clin Immunol; 2018 Mar; 188():12-19. PubMed ID: 29223406
[TBL] [Abstract][Full Text] [Related]
23. Towards routine screening of rare genetic diseases: the example of chronic granulomatous disease.
Stasia MJ
J Mol Diagn; 2010 May; 12(3):269-71. PubMed ID: 20304942
[TBL] [Abstract][Full Text] [Related]
24. AQP8 transports NOX2-generated H2O2 across the plasma membrane to promote signaling in B cells.
Bertolotti M; Farinelli G; Galli M; Aiuti A; Sitia R
J Leukoc Biol; 2016 Nov; 100(5):1071-1079. PubMed ID: 27256569
[TBL] [Abstract][Full Text] [Related]
25. Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease.
Buvelot H; Posfay-Barbe KM; Linder P; Schrenzel J; Krause KH
FEMS Microbiol Rev; 2017 Mar; 41(2):139-157. PubMed ID: 27965320
[TBL] [Abstract][Full Text] [Related]
26. X-linked chronic granulomatous disease misdiagnosed as non-Langerhans cell histiocytosis: A case report.
Tang X; Guo X; Gao J; Sun JJ
Scand J Immunol; 2021 Jan; 93(1):e12948. PubMed ID: 32697334
[No Abstract] [Full Text] [Related]
27. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
28. Disseminated Tuberculosis in a Patient with Autosomal Recessive p47
León-Lara X; Campos-Murguía A; León-Cabral P; Tello-Mercado A; Salgado-Nesme N; de la Mora JD; Dupuis SB; Bustamante J; Blancas-Galicia L
J Clin Immunol; 2021 Aug; 41(6):1417-1419. PubMed ID: 34013431
[No Abstract] [Full Text] [Related]
29. Chronic granulomatous disease caused by maternal uniparental isodisomy of chromosome 16.
Bravo García-Morato M; Nevado J; González-Granado LI; Sastre Urgelles A; Rodríguez Pena R; Ferreira Cerdán A
J Allergy Clin Immunol Pract; 2017; 5(4):1146-1148. PubMed ID: 28341171
[No Abstract] [Full Text] [Related]
30. A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease.
Bánfi B; Schrenzel J; Nüsse O; Lew DP; Ligeti E; Krause KH; Demaurex N
J Exp Med; 1999 Jul; 190(2):183-94. PubMed ID: 10432282
[TBL] [Abstract][Full Text] [Related]
31. Hematologically important mutations: X-linked chronic granulomatous disease--an update.
Heyworth PG; Curnutte JT; Noack D; Cross AR
Blood Cells Mol Dis; 1997 Dec; 23(3):443-50. PubMed ID: 9454688
[No Abstract] [Full Text] [Related]
32. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
Morel F
Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
[TBL] [Abstract][Full Text] [Related]
33. A New Chapter on Targeted Gene Insertion for X-CGD: Do Not Skip the Intro(n).
Santilli G; Thrasher AJ
Mol Ther; 2017 Feb; 25(2):307-309. PubMed ID: 28109956
[No Abstract] [Full Text] [Related]
34. p47phox deficiency induces macrophage dysfunction resulting in progressive crystalline macrophage pneumonia.
Liu Q; Cheng LI; Yi L; Zhu N; Wood A; Changpriroa CM; Ward JM; Jackson SH
Am J Pathol; 2009 Jan; 174(1):153-63. PubMed ID: 19095958
[TBL] [Abstract][Full Text] [Related]
35. Exploring the arachidonic acid-induced structural changes in phagocyte NADPH oxidase p47(phox) and p67(phox) via thiol accessibility and SRCD spectroscopy.
Bizouarn T; Karimi G; Masoud R; Souabni H; Machillot P; Serfaty X; Wien F; Réfrégiers M; Houée-Levin C; Baciou L
FEBS J; 2016 Aug; 283(15):2896-910. PubMed ID: 27284000
[TBL] [Abstract][Full Text] [Related]
36. CRISPR gene-engineered CYBB
Benyoucef A; Marchitto L; Touzot F
J Allergy Clin Immunol; 2020 Jun; 145(6):1690-1693.e5. PubMed ID: 31954113
[No Abstract] [Full Text] [Related]
37. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.
Freudenberg F; Wintergerst U; Roesen-Wolff A; Albert MH; Prell C; Strahm B; Koletzko S; Ehl S; Roos D; Tommasini A; Ventura A; Belohradsky BH; Seger R; Roesler J; Güngör T
J Allergy Clin Immunol; 2010 Apr; 125(4):943-946.e1. PubMed ID: 20371400
[No Abstract] [Full Text] [Related]
38. Optical Genomic Mapping Identified a Heterozygous Structural Variant in NCF2 Related to Chronic Granulomatous Disease.
Hui X; Yang J; Zhang J; Sun J; Wang X
J Clin Immunol; 2022 Nov; 42(8):1614-1617. PubMed ID: 35900637
[No Abstract] [Full Text] [Related]
39. Relationship between platelet and urinary 8-Iso-PGF2α levels in subjects with different degrees of NOX2 regulation.
Carnevale R; Iuliano L; Nocella C; Bartimoccia S; Trapè S; Russo R; Gentile MC; Cangemi R; Loffredo L; Pignatelli P; Violi F;
J Am Heart Assoc; 2013 Jun; 2(3):e000198. PubMed ID: 23770972
[TBL] [Abstract][Full Text] [Related]
40. Chronic granulomatous disease: why an inflammatory disease?
Roxo-Junior P; Simão HM
Braz J Med Biol Res; 2014 Nov; 47(11):924-8. PubMed ID: 25296353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
